Peng Sun
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Cancer Risks and Factors
Papers in
-
- MicroRNA in disease regulation 15
- Cancer-related molecular mechanisms research 15
- Cancer, Lipids, and Metabolism 8
- Oncology 43
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- S A NarodClare WallT. ToCornelia J. BainesAnthony B. MillerPing LiTinghuai WangJohn Laterra
- Journals
- BMC Cancer (5 papers)Tumor Biology (3 papers)Frontiers in Immunology (3 papers)Oncology Reports (3 papers)Frontiers in Microbiology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Peng Sun
212 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 656
- Oncology 804
- Neurology 241
- Behavioral Neuroscience 65
- Molecular Biology 1.1k
Countries citing papers authored by Peng Sun
This map shows the geographic impact of Peng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Sun more than expected).
Fields of papers citing papers by Peng Sun
This network shows the impact of papers produced by Peng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Sun. The network helps show where Peng Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 17 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 22 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 9 | |
| 13 | MicroRNA-1246 Promotes Melanoma Progression Through Targeting FOXA2 | 2020 | 1 |
| 14 | circPCNX and Pecanex Promote Hepatocellular Carcinoma Cell Viability by Inhibiting miR-506 | 2020 | 1 |
| 15 | 2017 | 6 | |
| 16 | [Adenovirus-mediated interleukin-24 enhanced the antitumor effect of radiotherapy on nasopharyngeal carcinoma in vitro and in vivo]. | 2013 | 1 |
| 17 | 2011 | 81 | |
| 18 | Qualitative research on caring experiences of female family caregivers of patients with dementia | 2010 | 2 |
| 19 | Grapevine yellow speckle viroid 1 and grapevine yellow speckle viroid 2 isolates from China. | 2007 | 2 |
| 20 | Proscript 519, proteasome inhibitor, reduces cortical neuronal injury following focal ischemia in rats | 2000 | 3 |
About Peng Sun
Peng Sun is a scholar working on Cancer Research, Oncology, Neurology, Otorhinolaryngology and Endocrinology, having authored 229 papers that have together received 3.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (13 papers), Ferroptosis and cancer prognosis (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers), RNA modifications and cancer (8 papers), Cancer, Lipids, and Metabolism (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Cancer Research (656 citations), Oncology (804 citations), Neurology (241 citations), Behavioral Neuroscience (65 citations) and Molecular Biology (1.1k citations). Peng Sun has collaborated with scholars based in China, United States and Canada. Frequent co-authors include S A Narod, Clare Wall, T. To, Cornelia J. Baines, Anthony B. Miller, Ping Li, Tinghuai Wang, John Laterra, Bachchu Lal and Shuli Xia. Their work appears in journals such as BMC Cancer, Tumor Biology, Frontiers in Immunology, Oncology Reports and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.